[1]苑文贺,史惠蓉*.子宫内膜复杂性不典型增生及早期子宫内膜癌患者保留生育功能的预后分析[J].中国计划生育和妇产科,2018,(１):23-27.
　YUAN Wen-he,SHI Hui-rong*.Prognosis analysis of fertility maintenance in women with complex endometrial hyperplasia or endometrial cancer[J].Chinese Journal of Family Planning & Gynecotokology,2018,(１):23-27.
点击复制

子宫内膜复杂性不典型增生及早期子宫内膜癌患者保留生育功能的预后分析
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2018年１期
页码:
23-27
栏目:
论著与临床
出版日期:
2018-01-25

文章信息/Info

Title:
Prognosis analysis of fertility maintenance in women with complex endometrial hyperplasia or endometrial cancer
作者:
苑文贺; 史惠蓉*
郑州大学第一附属医院妇产科
Author(s):
YUAN Wen-he;  SHI Hui-rong*
Department of Obstetrics and Gynecology，the First Affiliated Hospital of Zhengzhou University ，Zhengzhou Henan 450052，P.R.China
关键词:
子宫内膜复杂性不典型增生; 早期子宫内膜癌; 宫腔镜电切术; 曼月乐; 妊娠
Keywords:
complex endometrial hyperplasia; endometrial cancer; hysteroscopic resection; levonorgestrel intrauterine device
分类号:
R 71174
摘要:
目的评估宫腔镜电切术联合曼月乐和（或）高效孕激素保守治疗子宫内膜复杂性不典型增生(complex endometrial hyperplasia, CEH)及早期子宫内膜癌（endometrial carcinoma, EC）患者的完全缓解率、复发率、妊娠情况并分析其预后的相关影响因素。方法回顾性分析郑州大学第一附属医院2011年1月至2015年1月由组织学病理确诊为CEH或早期EC并用宫腔镜电切术联合曼月乐和（或）高效孕激素治疗的87例患者的临床资料，对患者治疗后每3个月行宫腔镜下检查并诊刮评估子宫内膜改善情况。结果87例患者中完全缓解77例（8851 ％），复发9例（1169 ％）；完全缓解患者中65例有妊娠愿望，治疗后自然妊娠或应用辅助生殖技术妊娠38例（5846 ％）。体质量指数（body mass index，BMI）＜30 kg/m2的患者更容易达到完全缓解；BMI＜30 kg/m2、完全缓解后妊娠可降低复发率；BMI＜30 kg/m2、应用辅助生殖技术可改善缓解后的妊娠结局。 结论对于强烈要求保留生育功能的CEH及早期EC患者，采用宫腔镜电切术联合曼月乐和（或）高效孕激素的保守治疗方式可获得较满意的疗效，且在明确影响完全缓解、复发及妊娠的因素后，给予相应处理有助于改善预后。
Abstract:
ObjectiveTo evaluate the complete remission rate, relapse rate and pregnancy status of hysteroscopic electrotomy combined with Mirena and / or progestin and conservative treatment of complex endometrial hyperplasia(CEH) and endometrial carcinoma(EC), and analyze the related factors of prognosis. MethodsThe clinical data of 87 patients who were histologically diagnosed as CEH or early EC combined with hysteroscopic electrotomy combined with Mirena and / or progestin in the First Affiliated Hospital of Zhengzhou University from January 2011 to January 2015 were retrospectively analyzed. Hysteroscopic examination and curettage evaluation of endometrial improvement were performed every 3 months after treatment. ResultsIn 87 cases, 77 cases (8851%) were completely relieved and 9 cases(1169%) were relapsed; 65 patients with complete remission had a pregnancy expectation. After treatment 38 cases(5846%) were of natural pregnancy or assisted reproductive technology of pregnancy. Patients with body mass index(BMI)<30 kg/m2 were more likely to achieve complete remission; BMI<30 kg/m2, were pregnant after complete remission can reduce the recurrence rate; BMI<30 kg/m2, the application of assisted reproductive technology could improve the outcome after remission of pregnancy. ConclusionFor patients with strong demand for retention of fertility in patients with early CE and CEH, the use of hysteroscopic resection combined with Mirena and (or) high-efficiency progesterone conservative treatment can lead to more satisfactory results. After the factors that affect the complete remission, relapse and pregnancy are clearly affected, the corresponding treatment can help to improve the prognosis.

参考文献/References:

［1］Falcone F, Laurelli G, Losito S, et al. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer ［J］. Gynecol Oncol, 2017, 28(1): e2. ［2］王永学，潘凌亚，黄惠芳，等．年轻子宫内膜癌患者孕激素保守治疗临床分析 ［J］．中华肿瘤防治杂志，2011，18（7）：541-544． ［3］ZHOU Rong, YANG Yuan, LU Qun, et al. Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients ［J］. Gynecol Oncol, 2015, 139(3): 424-428. ［4］Ando H, Miyamoto T, Kashima H, et al. Panobinostat enhances growth suppressive effects of progestin on endometrial carcinoma by increasing progesterone receptor and mitogen-inducible gene-6［J］. Horm Cancer, 2017, 8(4): 257-267. ［5］Rodolakis A, Biliatis I, Morice P, et al. European society of gynecological oncology task force for fertility preservation: clinical recommendations for Fertility-Sparing management in young endometrial cancer patients ［J］. Int J Gynecol Cancer, 2015, 25(7): 1258-1265. ［6］Park JY, Kim DY, Kim JH, et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)［J］. Eur J Cancer, 2013, 49(4): 868-874. ［7］Park JY, Seong SJ, Kim TJ, et al. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer ［J］. Obstet Gynecol, 2013, 121(1): 136-142. ［8］Gunderson CC, Fader AN, Carson KA, et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review ［J］. Gynecol Oncol, 2012, 125(2): 477-482. ［9］Park JY, Seong SJ, Kim TJ, et al. Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer ［J］. Gynecol Oncol, 2017, 146(1): 39-43. ［10］Gallos ID, Yap J, Rajkhowa M, et al. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis ［J］. Am J Obstet Gynecol, 2012, 207(4): 266.e1-266.e12. ［11］Gonthier C, Walker F, Luton D, et al. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer ［J］. Gynecol Oncol, 2014, 133(1): 33-37. ［12］XIE Ya, WANG Yan-ling, YU Li, et al. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells ［J］. J Steroid Biochem Mol Biol, 2011, 126(3/5): 113-120. ［13］Park JY, Kim DY, Kim JH, et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002) ［J］. Eur J Cancer, 2013, 49(4): 868-874. ［14］Lee WL, Lee FK, Su WH, et al. Hormone therapy for younger patients with endometrial cancer ［J］. Taiwan J Obstet Gynecol, 2012, 51(4): 495-505. ［15］Koplay M, Dogan NU, Erdogan H, et al. Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma ［J］. J Med Imaging Radiat Oncol, 2014, 58(5): 538-546， quiz 648.

相似文献/References:

[1]王建六.应重视和规范早期子宫内膜癌患者保留生育功能治疗[J].中国计划生育和妇产科,2019,(10):10.

更新日期/Last Update: 2018-01-25